• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转化酶 2(ACE2)作为 SARS-CoV-2 的受体,其生理和病理调节。

Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.

机构信息

Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, 210000, China; School of Medicine, Southeast University, Nanjing, 210000, China.

Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, 210000, China.

出版信息

Pharmacol Res. 2020 Jul;157:104833. doi: 10.1016/j.phrs.2020.104833. Epub 2020 Apr 14.

DOI:10.1016/j.phrs.2020.104833
PMID:32302706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7194807/
Abstract

The renin-angiotensin system (RAS) is crucial for the physiology and pathology of all the organs. Angiotensin-converting enzyme 2 (ACE2) maintains the homeostasis of RAS as a negative regulator. Recently, ACE2 was identified as the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus that is causing the pandemic of Coronavirus disease 2019 (COVID-19). Since SARS-CoV-2 must bind with ACE2 before entering the host cells in humans, the distribution and expression of ACE2 may be critical for the target organ of the SARS-CoV-2 infection. Moreover, accumulating evidence has demonstrated the implication of ACE2 in the pathological progression in tissue injury and several chronic diseases, ACE2 may also be essential in the progression and clinical outcomes of COVID-19. Therefore, we summarized the expression and activity of ACE2 in various physiological and pathological conditions, and discussed its potential implication in the susceptibility of SARS-CoV-2 infection and the progression and prognosis of COVID-19 patients in the current review.

摘要

肾素-血管紧张素系统(RAS)对于所有器官的生理和病理都至关重要。血管紧张素转换酶 2(ACE2)作为负调节剂维持 RAS 的内稳态。最近,ACE2 被确定为严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)的受体,SARS-CoV-2 是导致 2019 年冠状病毒病(COVID-19)大流行的冠状病毒。由于 SARS-CoV-2 在进入人体宿主细胞之前必须与 ACE2 结合,因此 ACE2 的分布和表达可能对 SARS-CoV-2 感染的靶器官至关重要。此外,越来越多的证据表明 ACE2 在组织损伤和几种慢性疾病的病理进展中具有重要作用,ACE2 在 COVID-19 的进展和临床结局中也可能至关重要。因此,我们总结了 ACE2 在各种生理和病理条件下的表达和活性,并在当前综述中讨论了其在 SARS-CoV-2 感染易感性以及 COVID-19 患者的进展和预后中的潜在意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee91/7194807/cfb7139d93fb/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee91/7194807/cfb7139d93fb/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee91/7194807/cfb7139d93fb/ga1_lrg.jpg

相似文献

1
Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.血管紧张素转化酶 2(ACE2)作为 SARS-CoV-2 的受体,其生理和病理调节。
Pharmacol Res. 2020 Jul;157:104833. doi: 10.1016/j.phrs.2020.104833. Epub 2020 Apr 14.
2
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
3
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.血管紧张素转换酶 2:SARS-CoV-2 受体和肾素-血管紧张素系统的调节剂:庆祝 ACE2 发现 20 周年。
Circ Res. 2020 May 8;126(10):1456-1474. doi: 10.1161/CIRCRESAHA.120.317015. Epub 2020 Apr 8.
4
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.SARS-CoV-2 大流行和研究空白:了解 SARS-CoV-2 与 ACE2 受体的相互作用及其对治疗的影响。
Theranostics. 2020 Jun 12;10(16):7448-7464. doi: 10.7150/thno.48076. eCollection 2020.
5
ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19.ACE2 两面蛋白——从心血管保护到严重急性呼吸综合征冠状病毒 2 和 COVID-19。
Clin Sci (Lond). 2020 Apr 17;134(7):747-750. doi: 10.1042/CS20200363.
6
Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2.人肠道防御素5通过覆盖血管紧张素转换酶2抑制新型冠状病毒2的入侵。
Gastroenterology. 2020 Sep;159(3):1145-1147.e4. doi: 10.1053/j.gastro.2020.05.015. Epub 2020 May 11.
7
Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?血管紧张素转换酶 2 的调节:预防 COVID-19 的潜在靶点?
Front Endocrinol (Lausanne). 2021 Oct 22;12:725967. doi: 10.3389/fendo.2021.725967. eCollection 2021.
8
Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2.ACE2 调节的内分泌方面:肾素-血管紧张素-醛固酮系统、类固醇激素和 SARS-CoV-2。
J Endocrinol. 2020 Nov;247(2):R45-R62. doi: 10.1530/JOE-20-0260.
9
COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.新型冠状病毒肺炎、肾素-血管紧张素系统与血管内皮功能障碍。
Cells. 2020 Jul 9;9(7):1652. doi: 10.3390/cells9071652.
10
ACE2 mouse models: a toolbox for cardiovascular and pulmonary research.ACE2 小鼠模型:心血管和肺部研究的工具包。
Nat Commun. 2020 Oct 14;11(1):5165. doi: 10.1038/s41467-020-18880-0.

引用本文的文献

1
Circulating angiotensin-converting enzyme 2 concentration is associated with acute kidney injury and mortality in sepsis.循环血管紧张素转换酶2浓度与脓毒症患者的急性肾损伤及死亡率相关。
PLoS One. 2025 Aug 29;20(8):e0330668. doi: 10.1371/journal.pone.0330668. eCollection 2025.
2
Gut microbiota and viral respiratory infections: microbial alterations, immune modulation, and impact on disease severity: a narrative review.肠道微生物群与病毒性呼吸道感染:微生物变化、免疫调节及对疾病严重程度的影响:一项叙述性综述
Front Microbiol. 2025 Jul 18;16:1605143. doi: 10.3389/fmicb.2025.1605143. eCollection 2025.
3
Soybean Trypsin Inhibitor Possesses Potency Against SARS-CoV-2 Infection by Blocking the Host Cell Surface Receptors ACE2, TMPRSS2, and CD147.

本文引用的文献

1
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.新型冠状病毒(SARS-CoV-2)受体ACE2的单细胞RNA表达谱分析
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. doi: 10.1164/rccm.202001-0179LE.
2
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.使用临床级别的可溶性人血管紧张素转化酶 2 抑制工程化人类组织中的 SARS-CoV-2 感染。
Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.
3
Kidney disease is associated with in-hospital death of patients with COVID-19.
大豆胰蛋白酶抑制剂通过阻断宿主细胞表面受体ACE2、TMPRSS2和CD147对SARS-CoV-2感染具有抑制作用。
Int J Mol Sci. 2025 Jul 9;26(14):6583. doi: 10.3390/ijms26146583.
4
Development and validation of COVID-19 with myocardial injury based on 3 methods.基于三种方法的新型冠状病毒肺炎合并心肌损伤的研究与验证
Medicine (Baltimore). 2025 Jun 27;104(26):e43142. doi: 10.1097/MD.0000000000043142.
5
Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入机制的受体结合:来自原始毒株和新出现变体的见解
Viruses. 2025 May 10;17(5):691. doi: 10.3390/v17050691.
6
SARS-CoV-2 Spike Protein and Long COVID-Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome.严重急性呼吸综合征冠状病毒2刺突蛋白与新冠后综合征——第2部分:了解刺突蛋白与细胞受体相互作用对新冠后综合征病理生理学的影响
Viruses. 2025 Apr 25;17(5):619. doi: 10.3390/v17050619.
7
Recent Advances in Field-Effect Transistor-Based Biosensors for Label-Free Detection of SARS-CoV-2.基于场效应晶体管的SARS-CoV-2无标记检测生物传感器的最新进展
Small Sci. 2023 Dec 21;4(2):2300058. doi: 10.1002/smsc.202300058. eCollection 2024 Feb.
8
Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection.N-连接糖基化位点在人血管紧张素转换酶2(ACE2)在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和人冠状病毒NL63(hCoV-NL63)感染中的作用
J Virol. 2025 May 20;99(5):e0220224. doi: 10.1128/jvi.02202-24. Epub 2025 Mar 28.
9
Cognitive Sequelae of COVID-19: Mechanistic Insights and Therapeutic Approaches.新冠病毒病的认知后遗症:机制洞察与治疗方法
CNS Neurosci Ther. 2025 Mar;31(3):e70348. doi: 10.1111/cns.70348.
10
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach.COVID-19住院患者死亡早期生物标志物的识别:基于LASSO的Cox和Logistic方法
Viruses. 2025 Feb 28;17(3):359. doi: 10.3390/v17030359.
肾病与 COVID-19 患者住院期间的死亡相关。
Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.
4
Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China.中国武汉 33 例感染新冠病毒的 COVID-19 产妇所生新生儿的早发性新生儿感染。
JAMA Pediatr. 2020 Jul 1;174(7):722-725. doi: 10.1001/jamapediatrics.2020.0878.
5
Antibodies in Infants Born to Mothers With COVID-19 Pneumonia.母亲患有 COVID-19 肺炎的婴儿体内的抗体。
JAMA. 2020 May 12;323(18):1848-1849. doi: 10.1001/jama.2020.4861.
6
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn.可能存在感染 SARS-CoV-2 的母亲将病毒垂直传播给新生儿的情况。
JAMA. 2020 May 12;323(18):1846-1848. doi: 10.1001/jama.2020.4621.
7
Perinatal Transmission of 2019 Coronavirus Disease-Associated Severe Acute Respiratory Syndrome Coronavirus 2: Should We Worry?2019冠状病毒病相关严重急性呼吸综合征冠状病毒2的围产期传播:我们应该担心吗?
Clin Infect Dis. 2021 Mar 1;72(5):862-864. doi: 10.1093/cid/ciaa226.
8
Epidemiology of COVID-19 Among Children in China.中国儿童 COVID-19 流行病学。
Pediatrics. 2020 Jun;145(6). doi: 10.1542/peds.2020-0702. Epub 2020 Mar 16.
9
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.单细胞 RNA 测序数据分析受体 ACE2 的表达揭示了不同人体器官易感染 2019-nCoV 的潜在风险。
Front Med. 2020 Apr;14(2):185-192. doi: 10.1007/s11684-020-0754-0. Epub 2020 Mar 12.
10
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.九名孕妇感染 COVID-19 的临床特征和宫内垂直传播潜力:病历回顾性研究。
Lancet. 2020 Mar 7;395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3. Epub 2020 Feb 12.